EMERALD — ElectroMagnetic imaging for a novel genERation of medicAL Devices

Results in brief

ElectroMagnetic imaging for a novel genERation of medicAL Devices

EMERALD (ElectroMagnetic imaging for a novel genERation of medicAL Devices) is the coherent action of leading European engineering groups involved in electromagnetic (EM) technology for medical imaging to form a cohort of highly-skilled researchers capable of accelerating the translation of this technology “from research bench to patient bedside”. Nowadays, medical imaging technologies play a key role to face the ever-growing number of challenges due to aging populations, as they are the essential clinical tool to deliver accurate initial diagnosis and monitor the evolution of disease over time. For this reason, a whole range of new imaging modalities is currently being developed to supplement and support current modalities. Among these technologies, one of the most promising is EM imaging, which involves the illumination of the portion of the body under investigation with low-power non-ionizing EM waves (in the microwave spectrum) and the use of the resultant backscattered signals to generate images of the internal structures of the body. Hence, the main scientific objective pursued by the EMERALD action is to accelerate translation of research in EM medical imaging into clinical prototypes. To this end, EMERALD has established a group of 13 early stage researchers who will be the European leaders in this field, through a unique scientific and training programme. Its main objectives are: - to set-up and support the first complete scientific and training programme in EM medical imaging at a European Level (and possibly worldwide); - to provide the Early Stage Researchers (ESR) with excellent, multi-disciplinary scientific training and a set of competitive, transferable skills; - to expose the ESRs to academic and non-academic sectors, improving their future career perspectives. In conclusion, all the planned objectives were reached despite restrictions due to covid-19. All the training workshops and schools were performed, mostly on line, as well as almost all secondments, some of them also on-line. The ESRs’ research activities were developed according to each career development plan, and disseminated through journal papers and presentations at international conferences to the relevant scientific communities, and via outreach events to the general public.

Data: CORDIS, © European Union

Project objective

EMERALD (ElectroMagnetic imaging for a novel genERation of medicAL Devices) is the coherent action of leading European engineering groups involved in electromagnetic (EM) technology for medical imaging to form a cohort of highly-skilled researchers capable of accelerating the translation of this technology “from research bench to patient bedside”. Nowadays, medical imaging technologies play a key role to face the ever-growing number of challenges due to aging populations, as they are the essential clinical tool to deliver accurate initial diagnosis and monitor the evolution of disease over time. For this reason, a whole range of new imaging modalities is currently being developed to supplement and support current modalities. Among these technologies, there is EM imaging, which involves the illumination of the portion of the body under investigation with low-power non-ionizing EM waves (in the microwave spectrum) and the use of the resultant backscattered signals to generate images of the internal structures of the body. The scientific objective pursued by the EMERALD action is to accelerate translation of research in EM medical imaging into clinical prototypes. To this end, EMERALD will establish a group of 13 outstanding early stage researchers who will be the European leaders in this field, through a unique scientific and training programme. The EMERALD trained researchers will drive the future developments of EM imaging technology, thanks to the targeted skills, they will attain, and their established connections with clinicians and stakeholders.The EMERALD consortium involves academic institutions, industrial partners, hospitals and university medical centers (as partner organizations). The success of EMERALD will ensure that all achieved innovative technological developments will be translated into benefits to the end user community and potentially taken to market, with an impact on both the European society and scientific community.

Original text from CORDIS.

Participants

POLITECNICO DI TORINO · TorinoCoordinatorItaly
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS · ParisFrance
CONSIGLIO NAZIONALE DELLE RICERCHE · RomaItaly
FCIENCIAS.ID - ASSOCIACAO PARA A INVESTIGACAO E DESENVOLVIMENTO DE CIENCIAS · LisbonPortugal
KEYSIGHT TECHNOLOGIES GMBH · LINZAustria
KING'S COLLEGE LONDON · LondonUnited Kingdom
MITOS MEDIKAL TEKNOLOJILER SANAYIVE TICARET ANONIM SIRKETI · ISTANBULTürkiye
PREDUZECE ZA SOFTVER, KONSALTING IDIZAJN WIPL-D DOO BEOGRAD · BEOGRADSerbia
TECHNISCHE UNIVERSITAET ILMENAU · IlmenauGermany
UNIVERSITY OF GALWAY · GalwayIreland

EMERALD · ElectroMagnetic imaging for a novel genERation of medicAL Devices

Results in brief

ElectroMagnetic imaging for a novel genERation of medicAL Devices

Project objective

Participants

Links